PH23966A - Imidazoquinozoline compounds as agent for treatment of nephritis - Google Patents
Imidazoquinozoline compounds as agent for treatment of nephritisInfo
- Publication number
- PH23966A PH23966A PH34703A PH34703A PH23966A PH 23966 A PH23966 A PH 23966A PH 34703 A PH34703 A PH 34703A PH 34703 A PH34703 A PH 34703A PH 23966 A PH23966 A PH 23966A
- Authority
- PH
- Philippines
- Prior art keywords
- nephritis
- agent
- treatment
- carbon atoms
- imidazoquinozoline
- Prior art date
Links
- 201000008383 nephritis Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 imidazoquinazoline compound Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP301986 | 1986-01-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH23966A true PH23966A (en) | 1990-01-23 |
Family
ID=11545619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH34703A PH23966A (en) | 1986-01-10 | 1987-01-09 | Imidazoquinozoline compounds as agent for treatment of nephritis |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4766126A (de) |
| EP (1) | EP0230234B1 (de) |
| JP (1) | JP2525787B2 (de) |
| KR (1) | KR870006898A (de) |
| AT (1) | ATE64095T1 (de) |
| DE (1) | DE3770481D1 (de) |
| PH (1) | PH23966A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2113115A1 (en) * | 1991-07-29 | 1993-02-18 | Vlad E. Gregor | Quinazoline derivatives as acetylcholinesterase inhibitors |
| US5707621A (en) * | 1994-08-31 | 1998-01-13 | Chugai Pharmaceutical Co., Ltd. | Supression of nephritis-induced protein excretion by anti-IL-8 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS604186A (ja) * | 1983-06-21 | 1985-01-10 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン化合物 |
| JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
-
1987
- 1987-01-06 US US07/000,800 patent/US4766126A/en not_active Expired - Fee Related
- 1987-01-09 DE DE8787100203T patent/DE3770481D1/de not_active Expired - Lifetime
- 1987-01-09 JP JP62003052A patent/JP2525787B2/ja not_active Expired - Lifetime
- 1987-01-09 EP EP87100203A patent/EP0230234B1/de not_active Expired - Lifetime
- 1987-01-09 PH PH34703A patent/PH23966A/en unknown
- 1987-01-09 AT AT87100203T patent/ATE64095T1/de active
- 1987-01-10 KR KR870000136A patent/KR870006898A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62252724A (ja) | 1987-11-04 |
| EP0230234A1 (de) | 1987-07-29 |
| KR870006898A (ko) | 1987-08-13 |
| JP2525787B2 (ja) | 1996-08-21 |
| DE3770481D1 (de) | 1991-07-11 |
| US4766126A (en) | 1988-08-23 |
| ATE64095T1 (de) | 1991-06-15 |
| EP0230234B1 (de) | 1991-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2113229A1 (en) | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof | |
| EP0353955A3 (de) | Chemische Verbindungen | |
| MY101614A (en) | Improvements in or relating to benzothiophene derivatives as antiasthmatic agents | |
| ZA86152B (en) | Pristinamycin iib derivatives,their preparation and compositions containing them | |
| GR3007401T3 (de) | ||
| CA2014521A1 (en) | 2-Substituted N,N'-Ditrimethoxybenzoyl Piperazines, a Preparation Process of the Same and Therapeutic Compositions Containing Them | |
| MY103502A (en) | Novel compounds | |
| GB9125970D0 (en) | New compounds | |
| GR3007219T3 (de) | ||
| ATE64095T1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
| EP0347880A3 (de) | Imidazo[2,1-b]benzothiazol-Verbindungen und diese enthaltende Antiulkus-Zubereitungen | |
| IL95377A0 (en) | Therapeutic agent for the treatment of peptic ulcer disease containing xanthine derivatives and some novel compounds of this type | |
| DE3864336D1 (en) | Aromatische thioaether. | |
| MY104048A (en) | New allylaminoethylazoles. | |
| ES2132255T3 (es) | Nuevos compuestos de flavilio farmaceuticamente activos. | |
| MY101628A (en) | Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them. | |
| EP0151094A3 (de) | Pharmakologisch aktive Imidazopyridinverbindungen | |
| DE3662039D1 (de) | Novel diamine derivatives | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| ATE189813T1 (de) | Prostaglandin-i-analoga | |
| MY104164A (en) | Heterocyclic compounds. | |
| CA2016300A1 (en) | Prostaglandin i analogue |